SERN | Southeast NBS & Genetics Regional Collaborative

Like us on Facebook! Follow SERC_Genetics on Twitter Subscribe to our RSS Feed
Login | Contact Us

COVID-19 is an emerging, rapidly evolving situation.

Telegenetics in SERC - Hans Andersson MD
Telegenetics in SERC  
2013 SERC-SERGG Annual Conference
Novant Health Winston Salem
Novant Health Multidisciplinary Cancer Clinic
Winston Salem, NC  
July 18th, 2013
Download Slides

About the Presentation
Dr. Andersson presents on Telegenics activities in SERC.

Presenter Biography
Hans C. Andersson, MD is the Karen Gore Chair of Human Genetics and Director of the Hayward Genetics Center at the Tulane University Medical School where he directs the Biochemical Genetics Lab. Dr. Andersson is the past President of the SouthEast Regional Genetics Group (SERGG), holds membership of numerous national societies including the Society of Pediatric Research and is a member of the Editorial Board of the Journal of Pediatrics. He is past Co-Chair of the National Coordinating Center Telegenetics Workgroup and a current CO-PI of the Southeast Regional Genetics Network (SERN).

Selected Publications by the Presenter
Selected Publications by the Presenter
(from a total of 50 publications)

Andersson HC, Kratz L, Kelley RDesmosterolosis Presenting with Multiple Congenital Anomalies and Profound Developmental Delay. Am J     Med Genet 113:315-319, 2002.

Andersson  HC, MA Krousel-Wood, KE Jackson, J Rice, IM Lubin.Medical Genetic Test Reporting in Molecular Cystic Fibrosis and Factor V                Leiden Tests Based On Reports Solicited From North American Laboratories. Gen in Med 4(5):324-7 2002.

Andersson HC,  Charrow J, Kaplan P, Mistry P, Pastores G, Prakesh-Cheng A, Rosenbloom BE, Scott R, Wappner RS, Weinreb NJ.                              Individualization of Long-term Enzyme Replacement Therapy for Gaucher Disease. Genet in Med  Feb 7:105-110, 2005.

Andersson HC, Narumanchi TC, Cunningham A, Bowdish B, Thoene J. Genetic/Metabolic Health Care Delivery During and After Katrina and   Rita, Molecular Genetics and Metabolism, 88:3-6, 2006.

Andersson HC, Kaplan P, Kacena K, J Yee. Eight-year clinical outcomes of long-term enzyme replacement therapy in 884 children with type 1          Gaucher disease, Pediatrics 2008; 122;1182-1190.

Andersson HC, Kaplan P, Kacena K, J Yee. Eight-year clinical outcomes of long-term enzyme replacement therapy in 884 children with type 1 Gaucher disease, Pediatr,122:1182, 2008

Andersson, Perry W, Bowdish B, P Floyd-Browning. Emergency preparedness for genetics centers, laboratories and patients: the SouthEast Region Genetics Collaborative strategic plan. Genet Med, ePub: June, 2011, October, 2011.

Home | About | Contact Us
This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $600,000.00 with 0 percent financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit